Publication | Closed Access

Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis

UrologyOncologyGenitourinary CancerMedicineClinical TrialsOligometastasis HypothesisCurative-intent Metastasis-directed TherapiesCancer TreatmentProstatic DiseasePharmacology